Recombinant multi-species PRPF3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PRPF3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The removal of introns from nuclear pre-mRNAs occurs on complexes called spliceosomes, which are made up of 4 small nuclear ribonucleoprotein (snRNP) particles and an undefined number of transiently associated splicing factors. This gene product is one of several proteins that associate with U4 and U6 snRNPs. Mutations in this gene are associated with retinitis pigmentosa-18. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 3632413F13Rik,HPRP3,HPRP3P,PRP3,PRPF3,Pre-mRNA-splicing factor 3 (hPrp3),Prp3p,Prpf3,RP18,SNRNP90,U4/U6 small nuclear ribonucleoprotein Prp3,U4/U6 snRNP 90 kDa protein
Go
to PRPF3 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP13507-Ag-1/ GM-Tg-hg-IP13507-Ag-2 | Human PRPF3 protein | Human |
| GM-Tg-rg-IP13507-Ag-1/ GM-Tg-rg-IP13507-Ag-2 | Rat PRPF3 protein | Rat |
| GM-Tg-mg-IP13507-Ag-1/ GM-Tg-mg-IP13507-Ag-2 | Mouse PRPF3 protein | Mouse |
| GM-Tg-cynog-IP13507-Ag-1/ GM-Tg-cynog-IP13507-Ag-2 | Cynomolgus/Rhesus macaque PRPF3 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP13507-Ag-1/ GM-Tg-felg-IP13507-Ag-2 | Feline PRPF3 protein | Feline |
| GM-Tg-cang-IP13507-Ag-1/ GM-Tg-cang-IP13507-Ag-2 | Canine PRPF3 protein | Canine |
| GM-Tg-bovg-IP13507-Ag-1/ GM-Tg-bovg-IP13507-Ag-2 | Bovine PRPF3 protein | Bovine |
| GM-Tg-equg-IP13507-Ag-1/ GM-Tg-equg-IP13507-Ag-2 | Equine PRPF3 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP13507-Ag-1/ GM-Tg-hg-IP13507-Ag-2;
GM-Tg-rg-IP13507-Ag-1/ GM-Tg-rg-IP13507-Ag-2;
GM-Tg-mg-IP13507-Ag-1/ GM-Tg-mg-IP13507-Ag-2; GM-Tg-cynog-IP13507-Ag-1/ GM-Tg-cynog-IP13507-Ag-2; GM-Tg-felg-IP13507-Ag-1/ GM-Tg-felg-IP13507-Ag-2; GM-Tg-cang-IP13507-Ag-1/ GM-Tg-cang-IP13507-Ag-2; GM-Tg-bovg-IP13507-Ag-1/ GM-Tg-bovg-IP13507-Ag-2; GM-Tg-equg-IP13507-Ag-1/ GM-Tg-equg-IP13507-Ag-2 |
| Products Name | PRPF3 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | PRPF3 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PRPF3 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.